Medibio: Raises $3.5M via placement and SPP

  • Health technology company Medibio (MEB) plans to raise up to $3.5 million through a capital raise and share purchase plan
  • The company has received commitments for a $3 million placement of around 333.3 million new fully paid ordinary shares
  • Medibio will offer investors one free attaching option for every four new shares issued at 1.5 cents per option
  • Medibio will also conduct a $500,000 share purchase plan, which expected to fully underwritten
  • Proceeds will fund a depressive burden trial, MEBsleep and ilumen product commercialisation activities and consumer app development
  • Medibio is up 11.11 per cent and trading at 1 cent per share
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Keye Launches AI Co-Pilot for Private Equity Due Diligence

A game-changing tool to enhance efficiency in investment evaluations.Highlights: Keye introduces an AI-powered co-pilot for due diligence.Streamlines the...

Regulators Urged to Prioritize Gen AI Threats Over Quantum Computing Risks

Insights on the evolving regulatory landscape in fintech and AI.Highlights: Exchange Association emphasizes urgency on Gen AI regulatory...

Cryptocurrency Scam Losses Surge to $17 Billion in 2025, Fuelled by AI

Analysis reveals AI-driven schemes are escalating crypto fraud incidences.Highlights: Losses from cryptocurrency scams reached $17 billion in 2025.AI...

Alpaca Surges to Unicorn Status in Fintech Landscape

A landmark achievement showcasing fintech innovation and disruption.Highlights: Alpaca reaches a valuation exceeding $1 billion.The firm specializes in...